Final results of feasibility study of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil (DCF) for clinical stage II/III esophageal squamous cell carcinoma.

H Hara,K Kato,H Igaki,S Kadowaki,H Daiko,H Matsushita,M Tahara,Y Tanaka,M Nagase,Y Hamamoto,Y Hosoya

doi:10.1200/jco.2011.29.15_suppl.4060

Final results of feasibility study of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil (DCF) for clinical stage II/III esophageal squamous cell carcinoma.

H Hara, K Kato + Show 9 more

https://doi.org/10.1200/jco.2011.29.15_suppl.4060

Copy DOI

Journal: Journal of Clinical Oncology	Publication Date: May 20, 2011
Citations: 8

#Esophageal Squamous Cell Carcinoma #Cisplatin Plus 5-fluorouracil + Show 7 more

Abstract
Full-Text PDF
Similar Papers

Abstract

4060 Background: The results of JCOG 9907 randomized trial of neoadjuvant chemotherapy with cisplatin plus 5-fluorouracil (CF) vs. adjuvant CF for stage II/III esophageal squamous cell carcinoma (E...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Journal of Clinical Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.